I
Initiator Pharma A/S
STO:INIT
Initiator Pharma A/S
STO:INIT
Price:
3.06
SEK
3.73%
Market Closed
Market Cap:
kr209.5m
Initiator Pharma A/S
Initiator Pharma A/S is a clinical-stage biotechnology company, which engages in the development of novel therapeutics within the field of mono-amine reuptake transporters targeting central nervous system (CNS)-disorders. The firm focuses on developing drugs for treatment of erectile dysfunction.
Initiator Pharma A/S
Business Overview
Initiator Pharma A/S is a clinical-stage biotechnology company, which engages in the development of novel therapeutics within the field of mono-amine reuptake transporters targeting central nervous system (CNS)-disorders. The firm focuses on developing drugs for treatment of erectile dysfunction.
No Earnings Calls Available
Management
Dr. Claus Elsborg Olesen
Co-Founder, CEO & Director
No Bio Available
Dr. Dan Peters
Co-Founder & CTO
No Bio Available
Prof. Ulf Simonsen Ph.D.
Co-Founder, CMO & CSO
No Bio Available
Dr. Mikael Thomsen M.Sc., Ph.D.
Co-Founder & Chief Development Officer
No Bio Available
Dr. Torgeir Vaage Ph.D.
Chief Financial Officer
No Bio Available
Dr. Allan Wehnert
Senior Vice President of Clinical and R&D Strategy & Portfolio Management
No Bio Available
Susanne Thomsen
Head of Clin Ops
No Bio Available
Rene Egebro M.Sc.
Head of CMC
No Bio Available
